John G Gribben Selected Research

Immunoglobulin Variable Region

12/2020	IGHV sequencing reveals acquired N-glycosylation sites as a clonal and stable event during follicular lymphoma evolution.
3/2007	Comprehensive assessment of genetic and molecular features predicting outcome in patients with chronic lymphocytic leukemia: results from the US Intergroup Phase III Trial E2997.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

John G Gribben Research Topics

Disease

59	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2022 - 07/2002
51	Neoplasms (Cancer) 11/2022 - 01/2002
29	Lymphoma (Lymphomas) 07/2023 - 03/2002
19	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2024 - 11/2006
17	Leukemia 01/2022 - 10/2004
10	Disease Progression 01/2022 - 08/2004
10	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2018 - 01/2002
9	Residual Neoplasm 01/2022 - 12/2003
8	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2022 - 01/2012
8	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 01/2002
7	B-Cell Lymphoma (Lymphoma, B Cell) 12/2023 - 07/2013
7	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2021 - 05/2006
5	Hodgkin Disease (Hodgkin's Disease) 01/2019 - 04/2012
4	Hematologic Neoplasms (Hematological Malignancy) 10/2016 - 03/2005
4	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 06/2015 - 12/2003
3	Multiple Myeloma 01/2022 - 06/2002
3	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2020 - 03/2002
2	Virus Diseases (Viral Diseases) 05/2023 - 01/2018
2	Neoplasm Metastasis (Metastasis) 10/2020 - 05/2005
2	Infections 10/2019 - 11/2018
2	Neutropenia 10/2019 - 11/2018
2	Autoimmune Diseases (Autoimmune Disease) 01/2018 - 01/2016
2	Acquired Immunodeficiency Syndrome (AIDS) 01/2015 - 07/2013
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 05/2006 - 01/2002
1	Thrombocytopenia (Thrombopenia) 05/2023
1	Hypertension (High Blood Pressure) 01/2022
1	Tertiary Lymphoid Structures 01/2021
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2021
1	Breast Neoplasms (Breast Cancer) 10/2020
1	Tumor Lysis Syndrome 01/2020
1	Leukopenia 10/2019
1	Neuroendocrine Carcinoma 01/2019
1	Sudden Death 01/2019
1	Carcinogenesis 01/2019

Drug/Important Bio-Agent (IBA)

16	Rituximab (Mabthera)FDA Link 07/2023 - 03/2002
10	obinutuzumabIBA 07/2023 - 08/2016
10	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 01/2022 - 07/2002
10	AntigensIBA 01/2017 - 09/2002
10	Immunoglobulins (Immunoglobulin)IBA 04/2009 - 03/2002
9	Lenalidomide (CC 5013)FDA Link 10/2019 - 09/2009
9	fludarabineIBA 11/2018 - 02/2004
8	Biomarkers (Surrogate Marker)IBA 06/2023 - 03/2008
8	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2018 - 03/2002
7	ibrutinibIBA 01/2022 - 01/2018
6	Chlorambucil (Leukeran)FDA Link 01/2022 - 04/2014
5	LigandsIBA 10/2016 - 08/2012
4	Chimeric Antigen ReceptorsIBA 01/2024 - 12/2013
4	Phosphotransferases (Kinase)IBA 01/2022 - 02/2014
4	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 06/2005
4	Doxorubicin (Adriamycin)FDA LinkGeneric 09/2015 - 03/2002
4	Monoclonal AntibodiesIBA 03/2009 - 01/2002
3	venetoclaxIBA 01/2020 - 01/2019
3	HMGB1 Protein (HMG1)IBA 01/2019 - 03/2014
3	Bendamustine Hydrochloride FDA Link 01/2018 - 08/2016
3	Isoantigens (Alloantigen)IBA 01/2016 - 09/2008
3	Prednisone (Sone)FDA LinkGeneric 09/2015 - 03/2002
3	Vincristine (Oncovin)FDA LinkGeneric 09/2015 - 03/2002
3	Proteins (Proteins, Gene)FDA Link 06/2014 - 01/2003
3	AntibodiesIBA 05/2013 - 08/2008
3	Alemtuzumab (Campath)FDA Link 01/2011 - 07/2006
2	axicabtagene ciloleucelIBA 01/2024 - 01/2022
2	NucleotidesIBA 01/2022 - 07/2014
2	cytidylyl-(3'-5')-cytidine (CpC)IBA 01/2022 - 02/2014
2	EnzymesIBA 01/2022 - 06/2015
2	Immunoglobulin Variable RegionIBA 12/2020 - 03/2007
2	AnthracyclinesIBA 10/2020 - 04/2012
2	CytokinesIBA 01/2018 - 01/2003
2	Bortezomib (Velcade)FDA Link 01/2012 - 11/2008
2	Actins (F Actin)IBA 09/2010 - 11/2009
1	GalliumIBA 07/2023
1	Thrombopoietin (c-mpl Ligand)IBA 05/2023
1	Ferritins (Ferritin)IBA 05/2023
1	Circulating Tumor DNAIBA 11/2022
1	Complement System Proteins (Complement)IBA 11/2022
1	Serine (L-Serine)FDA Link 01/2022
1	Lysine (L-Lysine)FDA Link 01/2022
1	Agammaglobulinaemia Tyrosine KinaseIBA 10/2021
1	Gemcitabine FDA Link 01/2021
1	ChemokinesIBA 01/2021
1	Estrogen ReceptorsIBA 10/2020
1	Progesterone Receptors (Progesterone Receptor)IBA 10/2020
1	Focal Adhesion Protein-Tyrosine KinasesIBA 10/2020
1	Phenobarbital (Luminal)FDA Link 10/2020
1	Tamoxifen FDA LinkGeneric 10/2020
1	CateninsIBA 01/2020
1	NF-kappa B (NF-kB)IBA 01/2020
1	ethyl pyruvateIBA 01/2019
1	ofatumumab FDA Link 11/2018

Therapy/Procedure

44	Therapeutics 01/2024 - 01/2002
20	Stem Cell Transplantation 01/2018 - 01/2002
15	Drug Therapy (Chemotherapy) 01/2021 - 01/2002
11	Immunotherapy 01/2021 - 06/2002
10	Hematopoietic Stem Cell Transplantation 01/2021 - 07/2003
8	Transplantation 01/2018 - 01/2002
6	Bone Marrow Transplantation (Transplantation, Bone Marrow) 09/2008 - 01/2003
3	Highly Active Antiretroviral Therapy (HAART) 01/2015 - 11/2012
2	Salvage Therapy 12/2023 - 06/2007
1	Precision Medicine 11/2022
1	Adjuvant Radiotherapy 10/2020
1	Neoadjuvant Therapy 10/2020